Assessment of the life quality of patients with multiple sclerosis using the SF-36 scale

The prevalence of multiple sclerosis (MS) is steadily increasing not only due to rising incidence, but also due to improvements in diagnosis and treatment. Accordingly, there is growing interest in improving the quality of life (QL) of chronic patients, for the assessment of which general scales are used, as well as scales developed specifically for MS. In this work, we analyzed publications devoted to assessing the quality of life of MS patients using the nonspecific SF-36 scale for the period from 2018 to 2023. Data were assessed on all eight scales: physical functioning, role functioning, bodily pain, general health, vitality, social functioning, emotional state and mental health. The usefulness of the SF-36 questionnaire has been shown in the management of patients with MS by a general practitioner for a comprehensive assessment of QL dynamics during treatment and in planning of further treatment and rehabilitation measures. However, the ambiguity of numerous QL studies results in MS obtained using the SF-36 questionnaire requires continued research and improvement of the instrument itself.

1. Clinical guidelines «Multiple Sclerosis». 2022. Available at: https://cr.minzdrav.gov.ru/schema/739_1 [In Russian].

2. Niino M., Fukumoto S., Okuno T., Sanjo N., Fukaura H., Mori M., Ohashi T., Takeuchi H., Shimizu Y., Fujimori J. … Mifune N. Health-related quality of life in Japanese patients with multiple sclerosis. J. Neurol. 2023;270(2):1011–1018. doi: 10.1007/s00415-022-11453-9

3. Oliva Ramirez A., Keenan A., Kalau O., Worthington E., Cohen L., Singh, S. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol. 2021;21(1):468. doi: 10.1186/s12883-021-02396-1

4. Gil-González I., Martín-Rodríguez A., Conrad R., Pérez-San-Gregorio M.Á. Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open. 2020;10(11):e041249. doi: 10.1136/bmjopen-2020-041249

5. Schmidt S., Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Mult. Scler. Relat. Disord. 2019;(35):262–269. doi: 10.1016/j.msard.2019.07.029

6. Ochoa-Morales A., Hernández-Mojica T., Paz-Rodríguez F., Jara-Prado A., Trujillo-De Los Santos Z., Sánchez-Guzmán M. A., Guerrero-Camacho J.L., Corona-Vázquez T., Flores J., Camacho-Molina A., Rivas-Alonso V., Dávila-Ortiz de Montellano D.J. Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability. Mult. Scler. Relat. Disord. 2019;(36):101386. doi: 10.1016/j.msard.2019.101386

7. The Multiple Sclerosis International Federation. Atlas of MS, 3rd Ed. Available at: https://www. msif.org/wp-content/uploads/2020/12/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf

8. The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Soc. Sci. Med. 1995;41(10):1403–1409. doi: 10.1016/0277-9536(95)00112-K

9. Wiebe S., Guyatt G., Weaver B., Matijevic S., Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J. Clin. Epidemiol. 2003;56(1):52–60. doi: 10.1016/s0895-4356(02)00537-1

10. Kuspinar A., Mayo N.E. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual. Life Outcomes. 2013;(11):71. doi: 10.1186/1477-7525-11-71

11. Kurtzke J.F. On the origin of EDSS. Mult. Scler. Relat. Disord. 2015;4(2):95–103. doi: 10.1016/j.msard.2015.02.003

12. Vickrey B.G., Hays R.D., Harooni R., Myers L.W., Ellison G.W. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 1995;4(3):187–206. doi: 10.1007/BF02260859

13. Simeoni M., Auquier P., Fernandez O., Flachenecker P., Stecchi S., Constantinescu C., Idiman E., Boyko A., Beiske A., Vollmer T., Beresniak A. MusiQol study group. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult. Scler. 2008;14(2):219–230. doi: 10.1177/1352458507080733

14. Ware J.E. Jr., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 1992;30(6):473–483.

15. Novik A.A., Ionova T.I. Guidelines for quality of life research in medicine. M., OLMA-PRESS, 2002. 314 p. [In Russian].

16. Pashazadeh Kan F., Hoseinipalangi Z., Ahmadi N., Hosseinifard H., Dehnad A., Sadat Hoseini B., Tohidi Asl M., Ghashghaee A. Global, regional and national quality of life in patients with multiple sclerosis: a global systematic review and meta-analysis. BMJ Support. Palliat. Care. 2022;12(2):158–166. doi: 10.1136/bmjspcare-2020-002604

17. Nikonova E.V., Abdullaev M.B., Pervunina A.V., Abroskina M.V. Work experience of the demyelination pathology unit in the city of krasnoyarsk related to investigation of the quality of life of patients with multiple sclerosis. Sibirskoe meditsinskoe obozrenie = Siberian Medical Review. 2021;(3):73–79. [In Russian]. doi: 10.20333/25000136-2021-3-73-79

18. Bojko A.N., Bakhtiyarova K.Z., Sherman M.A., Goncharova Z.A., Smagina I.V., Hajbullin T.I., Babicheva N.N., Spirina N.N., Yampol’skaya-Gosteva I.A., Sokolova I.A. ... Lozovskaya I.S. Results of the study of quality of life in patients with highly active multiple sclerosis in Russia. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(1S):9–15. [In Russian]. doi: 10.14412/2074-2711-2022-1S-9-15

19. Hyncicova E., Kalina A., Vyhnalek M., Nikolai T., Martinkovic L., Lisy J., Hort J., Meluzinova E., Laczó J. Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome. PloS One. 2018;13(7):e0200254. doi: 10.1371/journal.pone.0200254

20. Faraclas E., Lynn J., Lau J. D., Merlo A. Health-related quality of life in people with multiple sclerosis: How does this population compare to population-based norms in different health domains? J. Patient Rep. Outcomes. 2022;6(1):12. doi: 10.1186/s41687-022-00415-4

21. Zarubina N.V., Spirin N.N. Impact of depression on the quality of life of patients with multiple sclerosis. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(3):41–47. [In Russian]. doi: 10.14412/2074-2711-2023-3-41-47

22. Alhazzani A.A., Alqahtani M.S., Alahmari M.S., Asiri M.A., Alamri N.M., Sarhan L.A., Alkhashrami S.S., Asiri A.A. Quality of life assessment among multiple sclerosis patients in Saudi Arabia. Neurosciences (Riyadh). 2018;23(2):140–147. doi: 10.17712/nsj.2018.2.20170335

23. Lorina L.V., Dzhaparalieva N.T., Burshinov A.O. Quality of life indicators in different types of multiple sclerosis. Meditsina = Medicine. 2017;5(2):88–96. [In Russian].

24. Topuzova M.P., Alekseeva T.M., Panina E.B., Moskalyuk G.S. Assessment of quality of life in patients with multiple sclerosis: сoll. thes. rep. XXI Davidenkov Readings, Saint-Petersburg, September 26–27, 2019. Saint-Petersburg, 2019. P. 330–331. [In Russian].

25. Rezapour A., Almasian Kia A., Goodarzi S., Hasoumi M., Nouraei Motlagh S., Vahedi S. The impact of disease characteristics on multiple sclerosis patients’ quality of life. Epidemiol. Health. 2017;(39):e2017008. doi: 10.4178/epih.e2017008

26. Magyari M., Sorensen P.S. Comorbidity in multiple sclerosis. Front. Neurol. 2020;(11):851. doi: 10.3389/fneur.2020.00851

27. Lo L.M.P., Taylor B.V., Winzenberg T., Palmer A.J., Blizzard L., Ahmad H., Hussain M.A., van der Mei I. Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis. J. Neurol. 2021;268(2):569– 581. doi: 10.1007/s00415-020-10195-w

28. Strober L.B. Quality of life and psychological well-being in the early stages of multiple sclerosis (MS): Importance of adopting a biopsychosocial model. Disabil. Health J. 2018;11(4):555–561. doi: 10.1016/j.dhjo.2018.05.003

29. Schmidt S., Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Mult. Scler. Relat. Disord. 2019;(35):262–269. doi: 10.1016/j.msard.2019.07.029

30. Russell R.D., Black L.J., Pham N.M., Begley A. The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysis. Mult. Scler. Relat. Disord. 2020;(44):102171. doi: 10.1016/j.msard.2020.102171

31. Simpson R., Posa S., Langer L., Bruno T., Simpson S., Lawrence M., Booth J., Mercer S.W., Feinstein A., Bayley M. A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis. Journal of Neurology. 2023;270(2):726–745. doi: 10.1007/s00415-022-11451-x

32. Dunne J., Chih H. J., Begley A., Daly A., Gerlach R., Schütze R., Castell E., Byrne J., Black. J. A randomised controlled trial to test the feasibility of online mindfulness programs for people with multiple sclerosis. Mult. Scler. Relat. Disord. 2021;(48):102728. doi: 10.1016/j.msard.2020.102728